Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies

Journal of Neuroinflammation

Samuel J Listwak¹  Pierre Brown¹  Priyanka Rathore¹  Miles Herkenham¹ 

[1] Section on Functional Neuroanatomy, Laboratory of Cellular & Molecular Regulation, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA

关键词: antibody specificity;    immunohistochemistry;    transcription factor;    NF-κB;   

Others  :  1213058
DOI  :  10.1186/1742-2094-8-141

 received in 2011-08-23, accepted in 2011-10-14,  发布年份 2011

【 摘 要 】

Background

The characterization and cellular localization of transcription factors like NF-κB requires the use of antibodies for western blots and immunohistochemistry. However, if target protein levels are low and the antibodies not well characterized, false positive data can result. In studies of NF-κB activity in the CNS, antibodies detecting NF-κB proteins have been used to support the finding that NF-κB is constitutively active in neurons, and activity levels are further increased by neurotoxic treatments, glutamate stimulation, or elevated synaptic activity. The specificity of the antibodies used was analyzed in this study.

Methods

Selectivity and nonselectivity of commonly used commercial and non-commercial p50 and p65 antibodies were demonstrated in western blot assays conducted in tissues from mutant gene knockout mice lacking the target proteins.

Results

A few antibodies for p50 and p65 each mark a single band at the appropriate molecular weight in gels containing proteins from wildtype tissue, and this band is absent in proteins from knockout tissues. Several antibodies mark proteins that are present in knockout tissues, indicating that they are nonspecific. These include antibodies raised against the peptide sequence containing the nuclear localization signals of p65 (MAB3026; Chemicon) and p50 (sc-114; Santa Cruz). Some antibodies that recognize target proteins at the correct molecular weight still fail in western blot analysis because they also mark additional proteins and inconsistently so. We show that the criterion for validation by use of blocking peptides can still fail the test of specificity, as demonstrated for several antibodies raised against p65 phosphorylated at serine 276. Finally, even antibodies that show specificity in western blots produce nonspecific neuronal staining by immunohistochemistry.

Conclusions

We note that many of the findings in the literature about neuronal NF-κB are based on data garnered with antibodies that are not selective for the NF-κB subunit proteins p65 and p50. The data urge caution in interpreting studies of neuronal NF-κB activity in the brain.

【 授权许可】

   
2011 Herkenham et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Hayden MS, Ghosh S: Signaling to NF-κB. Genes Dev 2004, 18:2195-2224.
• [2]Hayden MS, Ghosh S: NF-κB in immunobiology. Cell Res 2011, 21:223-244.
• [3]Kaltschmidt B, Kaltschmidt C: NF-κB in the nervous system. Cold Spring Harb Perspect Biol 2009, 1:a001271.
• [4]Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995, 376:167-170.
• [5]Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D: NF-κB functions in synaptic signaling and behavior. Nat Neurosci 2003, 6:1072-1078.
• [6]Sha WC, Liou HC, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995, 80:321-330.
• [7]Artis D, Shapira S, Mason N, Speirs KM, Goldschmidt M, Caamano J, Liou HC, Hunter CA, Scott P: Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation. J Immunol 2002, 169:4481-4487.
• [8]Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D: Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J Immunol 2001, 167:1592-1600.
• [9]Goslin K, Banker G: Rat hippocampal neurons in low density culture. In Culturing nerve cells. Edited by Banker G, Goslin K. Cambridge, MA: MIT Press; 1992:252-281.
• [10]Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA: Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe Seyler 1995, 376:9-16.
• [11]Zhong H, Voll RE, Ghosh S: Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998, 1:661-671.
• [12]Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G: Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem Pharmacol 2002, 64:963-970.
• [13]Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G: Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). Embo J 2003, 22:1313-1324.
• [14]Spooren A, Kolmus K, Vermeulen L, Van Wesemael K, Haegeman G, Gerlo S: Hunting for serine 276-phosphorylated p65. J Biomed Biotechnol 2010, 2010:275892.
• [15]Matsuoka Y, Kitamura Y, Okazaki M, Terai K, Taniguchi T: Kainic acid-induced activation of nuclear factor-κB in rat hippocampus. Exp Brain Res 1999, 124:215-222.
• [16]Perez-Otano I, McMillian MK, Chen J, Bing G, Hong JS, Pennypacker KR: Induction of NF-κB-like transcription factors in brain areas susceptible to kainate toxicity. Glia 1996, 16:306-315.
• [17]Terai K, Matsuo A, McGeer EG, McGeer PL: Enhancement of immunoreactivity for NF-κB in human cerebral infarctions. Brain Res 1996, 739:343-349.
• [18]Voutsinos-Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A, Motte J: Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 2004, 17:385-402.
• [19]Nadjar A, Combe C, Laye S, Tridon V, Dantzer R, Amedee T, Parnet P: Nuclear factor κB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse. J Neurochem 2003, 87:1024-1036.
• [20]Quan N, Whiteside M, Kim L, Herkenham M: Induction of inhibitory factor κBα mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc Natl Acad Sci USA 1997, 94:10985-10990.
• [21]Laflamme N, Lacroix S, Rivest S: An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 1999, 19:10923-10930.
• [22]Gabriel C, Justicia C, Camins A, Planas AM: Activation of nuclear factor-κB in the rat brain after transient focal ischemia. Brain Res Mol Brain Res 1999, 65:61-69.
• [23]Sanz O, Acarin L, Gonzalez B, Castellano B: NF-κB and IκBα expression following traumatic brain injury to the immature rat brain. J Neurosci Res 2002, 67:772-780.
• [24]Acarin L, Gonzalez B, Castellano B: Stat3 and NFκB glial expression after excitotoxic damage to the postnatal brain. Neuroreport 1998, 9:2869-2873.
• [25]Acarin L, Gonzalez B, Castellano B: STAT3 and NFκB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J Neuropathol Exp Neurol 2000, 59:151-163.
• [26]Tounai H, Hayakawa N, Kato H, Araki T: Immunohistochemical study on distribution of NF-κB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin. Metab Brain Dis 2007, 22:89-104.
• [27]Zabel U, Henkel T, Silva MS, Baeuerle PA: Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 1993, 12:201-211.
• [28]Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA: Constitutive NF-κB activity in neurons. Mol Cell Biol 1994, 14:3981-3992.
• [29]Kaltschmidt C, Kaltschmidt B, Baeuerle PA: Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc Natl Acad Sci USA 1995, 92:9618-9622.
• [30]Wellmann H, Kaltschmidt B, Kaltschmidt C: Retrograde transport of transcription factor NF-κB in living neurons. J Biol Chem 2001, 276:11821-11829.
• [31]Kaltschmidt C, Kaltschmidt B, Baeuerle PA: Brain synapses contain inducible forms of the transcription factor NF-κB. Mech Dev 1993, 43:135-147.
• [32]Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M: NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999, 5:554-559.
• [33]Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, Smith DH: Prolonged activation of NF-κB following traumatic brain injury in rats. J Neurotrauma 1999, 16:1023-1034.
• [34]Blondeau N, Widmann C, Lazdunski M, Heurteaux C: Activation of the nuclear factor-κB is a key event in brain tolerance. J Neurosci 2001, 21:4668-4677.
• [35]Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J: Nuclear factor-κB contributes to infarction after permanent focal ischemia. Stroke 2004, 35:987-991.
• [36]Juttler E, Inta I, Eigler V, Herrmann O, Maegele I, Maser-Gluth C, Schwaninger M: Neuronal NF-κB influences thermoregulation and survival in a sepsis model. J Neuroimmunol 2007.
• [37]Pereira DS, Kushner DB, Ricciardi RP, Graham FL: Testing NF-κB1-p50 antibody specificity using knockout mice. Oncogene 1996, 13:445-446.
• [38]Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR: NF-κB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res 2006, 1088:167-175.
• [39]Pennypacker KR, Kassed CA, Eidizadeh S, Saporta S, Sanberg PR, Willing AE: NF-κB p50 is increased in neurons surviving hippocampal injury. Exp Neurol 2001, 172:307-319.
• [40]Won SJ, Ko HW, Kim EY, Park EC, Huh K, Jung NP, Choi I, Oh YK, Shin HC, Gwag BJ: Nuclear factor κB-mediated kainate neurotoxicity in the rat and hamster hippocampus. Neuroscience 1999, 94:83-91.
• [41]Caba E, Bahr BA: Biphasic NF-κB activation in the excitotoxic hippocampus. Acta Neuropathol (Berl) 2004, 108:173-182.
• [42]Scholz WK, Palfrey HC: Glutamate-stimulated protein phosphorylation in cultured hippocampal pyramidal neurons. J Neurosci 1991, 11:2422-2432.
• [43]Mao XR, Moerman-Herzog AM, Chen Y, Barger SW: Unique aspects of transcriptional regulation in neurons--nuances in NFκB and Sp1-related factors. J Neuroinflammation 2009, 6:16. BioMed Central Full Text
• [44]Freudenthal R, Romano A, Routtenberg A: Transcription factor NF-κB activation after in vivo perforant path LTP in mouse hippocampus. Hippocampus 2004, 14:677-683.
• [45]O'Sullivan NC, Croydon L, McGettigan PA, Pickering M, Murphy KJ: Hippocampal region-specific regulation of NF-κB may contribute to learning-associated synaptic reorganisation. Brain Res Bull 2010, 81:385-390.
• [46]Cohen H, Kozlovsky N, Matar MA, Zohar J, Kaplan Z: The Characteristic Long-Term Upregulation of Hippocampal NF-κB Complex in PTSD-Like Behavioral Stress Response Is Normalized by High-Dose Corticosterone and Pyrrolidine Dithiocarbamate Administered Immediately after Exposure. Neuropsychopharmacology 2011.
• [47]Gu Z, Cain L, Werrbach-Perez K, Perez-Polo JR: Differential alterations of NF-κB to oxidative stress in primary basal forebrain cultures. Int J Dev Neurosci 2000, 18:185-192.
• [48]Ganchi PA, Sun SC, Greene WC, Ballard DW: I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell 1992, 3:1339-1352.
• [49]Clemens JA, Stephenson DT, Dixon EP, Smalstig EB, Mincy RE, Rash KS, Little SP: Global cerebral ischemia activates nuclear factor-κB prior to evidence of DNA fragmentation. Brain Res Mol Brain Res 1997, 48:187-196.
• [50]Dixon EP, Stephenson DT, Clemens JA, Little SP: Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res 1997, 776:222-229.
• [51]Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, Clemens J: Transcription factor nuclear factor-κB is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 2000, 20:592-603.
• [52]Ward NL, Hagg T: SEK1/MKK4, c-Jun and NFκB are differentially activated in forebrain neurons during postnatal development and injury in both control and p75NGFR-deficient mice. Eur J Neurosci 2000, 12:1867-1881.
• [53]Denis-Donini S, Caprini A, Frassoni C, Grilli M: Members of the NF-κB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain. Brain Res Dev Brain Res 2005, 154:81-89.
• [54]Nadeau S, Rivest S: Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor κB activity in the brain during endotoxemia. J Neurosci 2000, 20:3456-3468.
• [55]Brochu S, Olivier M, Rivest S: Neuronal activity and transcription of proinflammatory cytokines, IκBa, and iNOS in the mouse brain during acute endotoxemia and chronic infection with Trypanosoma brucei brucei. J Neurosci Res 1999, 57:801-816.
• [56]Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N: Involvement of spinal cord nuclear factor κB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 2005, 22:1977-1986.
• [57]Quan N, Whiteside M, Herkenham M: Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998, 83:281-293.
• [58]Quan N, Stern EL, Whiteside MB, Herkenham M: Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 1999, 93:72-80.
• [59]Nadeau S, Rivest S: Regulation of the gene encoding tumor necrosis factor α (TNF-α) in the rat brain and pituitary in response in different models of systemic immune challenge. J Neuropathol Exp Neurol 1999, 58:61-77.
• [60]Quan N, Mhlanga JD, Whiteside MB, McCoy AN, Kristensson K, Herkenham M: Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei. J Comp Neurol 1999, 414:114-130.
• [61]Herx LM, Rivest S, Yong VW: Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1β is required for the production of ciliary neurotrophic factor. J Immunol 2000, 165:2232-2239.
• [62]De Lorenzi R, Gareus R, Fengler S, Pasparakis M: GFP-p65 knock-in mice as a tool to study NF-κB dynamics in vivo. Genesis 2009, 47:323-329.
• [63]Barger SW, Moerman AM, Mao X: Molecular mechanisms of cytokine-induced neuroprotection: NFκB and neuroplasticity. Curr Pharm Des 2005, 11:985-998.